• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Lightbeam Health Solutions Acquires RPM Platform CareSignal

by Fred Pennic 11/15/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Lightbeam Health Solutions, Inc., a provider of end-to-end population health management solutions, announced today the acquisition of CareSignal, the pioneer of Deviceless Remote Patient Monitoring technology. Financial details of the acquisition were not disclosed.

– The acquisition enables Lightbeam to integrate scalable, evidence-based remote engagement and monitoring capabilities into its core population health offering, which serves more than 42 million patient lives across the United States.

Deviceless Remote Patient Monitoring for Value-Based Care Organizations

CareSignal offers Deviceless Remote Patient Monitoring: SMS (text message) and phone-based engagement programs specifically designed for value-based care. The company leverages real-time, self-reported patient data and artificial intelligence to produce long-term patient engagement while identifying clinically actionable moments for proactive care delivery. Proven in 13 peer-reviewed studies and dozens of payer and provider implementations to sustainably scale care teams to manage over ten times more patients, CareSignal drives significant improvements in chronic and behavioral health outcomes, quality measures, and reduced global utilization.

Acquisition Impact for Lightbeam

Together, Lightbeam and CareSignal will deliver best-in-class population-level stratification, actionable real-time insight delivery, and clinical outcome improvement. Current and future industry partners of both companies will benefit from the validated offerings and deep focus on client success.

CareSignal brings over 30 condition-specific programs, proven real-world ROI, and a suite of robust AI-based predictive models that complement Lightbeam’s sophisticated population health analytics platform. Combined with the real-time cohort generation capabilities at the core of Lightbeam, CareSignal programs covering chronic conditions, behavioral health, social determinants of health, maternal health, and additional use cases will rapidly generate scalable returns on investment for value-based providers, payers, and self-insured employers.

“Lightbeam and CareSignal share a vision for the future of healthcare: care that is proactive, cost-effective, and data-driven. Lightbeam continues to see double-digit year-over-year growth, and CareSignal will help further accelerate our mission to deliver a revolutionary approach to population and risk management,” said Lightbeam Founder and CEO, Pat Cline.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions, Lightbeam Health Solutions, remote patient monitoring

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |